Impact of a multidisciplinary approach in clinical research on cardiovascular prognosis and patients' quality of life
Keywords:
clinical investigation, multidisciplinary team, healthcare, cardiovascular riskAbstract
Background and aim: Circulatory system diseases, including cardiovascular diseases, are among the leading causes of death worldwide. This study aimed at implementing a structured project to monitor patients attending clinical research consultations in Cardiology, through a multidisciplinary healthcare team.
Research design and methods: A multidisciplinary consultation model was developed and implemented, comparing a control group (Group A, without intervention) and an intervention group (Group B). The study assessed five data collection moments and analysis, including sociodemographic characterization, risk factors, anthropometric assessment, therapeutic adherence (using the Measure Treatment Adherence [MTA] scale), and quality of life (assessed via the EQ Visual Analogue Scale [EQ VAS], part of the EQ-5D-5L scale). Statistical analysis was conducted using SPSS (Statistical Package for the Social Sciences), version 28.0 for Windows.
Results and discussion: The anthropometric assessment showed no significant improvement, with both groups maintaining stable weight and BMI values at pre-obesity levels. The parameters remained stable over the follow-up, suggesting that the multidisciplinary intervention and consistent monitoring helped preserve these health indicators. However, significant improvements in therapeutic adherence and quality of life were observed over time in both groups. The increase in therapeutic adherence was significantly greater in Group B, t(432) = -9.046, p < .001, as was the increase in quality of life, t(435) = -5.674, p < .001.
Conclusions: The study highlights the value of structured consultations, supported by a trained and professionalized multidisciplinary team, in enhancing health indicators and the quality of life of patients with cardiovascular diseases.
References
1. Instituto Nacional de Estatística. Causas de Morte: menos mortes por doenças do aparelho circulatório. 2025
2. World Heart Report 2023: Confronting the World’s Number One Killer. Geneva, Switzerland. World Heart Federation. 2023.
3. Di Cesare M, Perel P, Taylor S, et al. The Heart of the World. Glob Heart. 2024 Jan 25;19(1):11. doi: 10.5334/gh.1288.
4. Chatzinikolaou A, Tzikas S, Lavdaniti M. Assessment of Quality of Life in Patients With Cardiovascular Disease Using the SF-36, MacNew, and EQ-5D-5L Questionnaires. Cureus. 2021 Sep 14;13(9):e17982. doi: 10.7759/cureus.17982.
5. Luengo-Fernandez R, Walli-Attaei M, Gray A, et al. Economic burden of cardiovascular diseases in the European Union: a population-based cost study. Eur Heart J. 2023 Dec 1;44(45):4752-67. doi: 10.1093/eurheartj/ehad583.
6. Qu C, Liao S, Zhang J, et al. Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. Eur Heart J Qual Care Clin Outcomes. 2024 Mar 1;10(2):143-53. doi: 10.1093/ehjqcco/qcad033.
7. Tamargo J, Agewall S, Borghi C, et al. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022. Eur Heart J Cardiovasc Pharmacother. 2023 May 11;9(4):353–70. doi: 10.1093/ehjcvp/pvad034.
8. Andrade N, Alves E, Costa AR, Moura-Ferreira P, Azevedo A, Lunet N. Knowledge about cardiovascular disease in Portugal. Rev Port de Cardio (Engl Ed). 2018 Aug; 37(8), 669–77. [English, Portuguese]. doi: 10.1016/j.repc.2017.10.017.
9. Mensah GA, Roth GA, Fuster V. The Global Burden of Cardiovascular Diseases and Risk Factors: 2020 and Beyond. J Am Coll Cardiol. 2019 Nov 19;74(20):2529-32. doi: 10.1016/j.jacc.2019.10.009.
10. Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020 Mar 7;395(10226):795-808. doi: 10.1016/S0140-6736(19)32008-2.
11. Global Cardiovascular Risk Consortium; Magnussen C, Ojeda FM, et al. Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality. N Engl J Med. 2023 Oct 5;389(14):1273-85. doi: 10.1056/NEJMoa2206916.
12. Regitz-Zagrosek V, Gebhard C. Gender medicine: effects of sex and gender on cardiovascular disease manifestation and outcomes. Nat Rev Cardiol. 2023 Apr. 20;20(4):236–47. doi: 10.1038/s41569-022-00797-4.
13. Pietri P, Stefanadis C. Cardiovascular aging and longevity: JACC state-of-the-art review.J Am Coll Cardiol. 2021 Jan;77(2),189-204. doi: 10.1016/j.jacc.2020.11.023.
14. Portugal. Plano Nacional de Saúde 2030. Planear para a Saúde Sustentável – Guia de apoio ao planeamento subnacional em saúde sustentável. Direção-Geral da Saúde. Lisboa. 2024.
15. Handbook for national quality policy and strategy: a practical approach for developing policy and strategy to improve quality of care. Geneva: World Health Organization; 2018. ISBN: 9789241565561.
16. Poitras ME, Maltais ME, Bestard-Denommé L, Stewart M, Fortin M. What are the effective elements in patient-centered and multimorbidity care? A scoping review. BMC Health Serv Res. 2018 Jun;18(1):446. doi: 10.1186/s12913-018-3213-8.
17. Iroegbu C, Tuot DS, Lewis L, Matura LA. The influence of patient-provider communication on self-management among patients with chronic illness: a systematic mixed studies review. J Adv Nurs. 2025 Apr;81(4):1678–99. doi: 10.1111/jan.16492.
18. Kwame A, Petrucka PM. A literature-based study of patient-centered care and communication in nurse-patient interactions: barriers, facilitators, and the way forward. BMC Nurs. 2021 Sep 3;20(1):158. doi: 10.1186/s12912-021-00684-2.
19. Vijn TW, Wollersheim H, Faber MJ, Fluit CRMG, Kremer JAM. Building a patient-centered and interprofessional training program with patients, students and care professionals: study protocol of a participatory design and evaluation study. BMC Health Serv Res. 2018 May 30;18(1):387. doi: 10.1186/s12913-018-3200-0.
20. Edgman-Levitan S, Schoenbaum SC. Patient-centered care: achieving higher quality by designing care through the patient's eyes. Isr J Health Policy Res. 2021 Mar 5;10(1):21. doi: 10.1186/s13584-021-00459-9.
21. Abid MH, Abid MM, Surani S, Ratnani I. Patient Engagement and Patient Safety: Are We Missing the Patient in the Center? Cureus. 2020 Feb 19;12(2):e7048. doi: 10.7759/cureus.7048.
22. McPake B, Dayal P, Zimmermann J, Williams GA. What steps can improve and promote investment in the health and care workforce? Enhancing efficiency of spending and rethinking domestic and international financing [Internet]. Copenhagen (Denmark): European Observatory on Health Systems and Policies; 2023. PMID: 37585574.
23. Delgado AB, Lima ML. Contributo para a validação concorrente de uma medida de adesão aos tratamentos. Psico: Saúde e Doen. 2001;2(2):81-100. [Portuguese].
24. Ferreira PL, Ferreira LN, Pereira LN. Contributos para a Validação da Versão Portuguesa do EQ-5D [Contribution for the validation of the Portuguese version of EQ-5D]. Acta Med Port. 2013;26(6):664-75. [Portuguese]. PMID: 24388252.
25. McEvoy JW, McCarthy CP, Bruno RM et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J 2024 Oct; 45(38): 3912–4018. doi: .10.1093/eurheartj/ehae178.
26. Processo Assistencial Integrado da Pré-Obesidade no Adulto. Departamento da Qualidade na Saúde. 2016 Oct. ISBN 978-972-675-215-8.
27. Smolderen KG, Gillaspy S, Evers AWM et al. The Role of the Clinical Psychologist in the Care of Adults With Cardiovascular Disease. JACC Adv. 2024 Mar 14;3(4):100910. doi: 10.1016/j.jacadv.2024.100910.
28. Zambetti E, Crepaldi M, Lanfranchi F, et al. Can psychological interventions affect cardiac rehabilitation patients’ well-being? Preliminary results from a longitudinal study. Int J Cardiol Cardiovasc Risk Prev. 2025 Set;26:200474. doi: 10.1016/j.ijcrp.2025.200474.
29. Tyrovola D, Soulaidopoulos S, Tsioufis C, Lazaros G. The Role of Nutrition in Cardiovascular Disease: Current Concepts and Trends. Nutrients. 2023 Feb 21;15(5):1064. doi: 10.3390/nu15051064.
30. Platz E, Jhund PS, Claggett BL, et al. Prevalence and prognostic importance of precipitating factors leading to heart failure hospitalization: recurrent hospitalizations and mortality. Eur J Heart Fail. 2018 Feb;20(2):295-303. doi: 10.1002/ejhf.901.
31. Leslie KH, McCowan C, Pell JP. Adherence to cardiovascular medication: a review of systematic reviews. J Public Health (Oxf). 2019 Mar 1;41(1):e84-e94. doi: 10.1093/pubmed/fdy088.
32. Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM. Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials. J Am Heart Assoc. 2016 Jun 17;5(6):e002606. doi: 10.1161/JAHA.115.002606.
33. Alcañiz M, Solé-Auró A. Feeling good in old age: factors explaining health-related quality of life. Health Qual Life Outcomes. 2018 Mar 13;16(1):48. doi: 10.1186/s12955-018-0877-z.
34. Magnani JW, Mujahid MS, Aronow HD, et al. Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association. Circulation. 2018 Jul 10;138(2):e48-e74. doi: 10.1161/CIR.0000000000000579.
35. Kanejima Y, Shimogai T, Kitamura M, Ishihara K, Izawa KP. Impact of health literacy in patients with cardiovascular diseases: A systematic review and meta-analysis. Patient Educ Couns. 2022 Jul;105(7):1793-800. doi: 10.1016/j.pec.2021.11.021.
36. Fitzpatrick PJ. Improving health literacy using the power of digital communications to achieve better health outcomes for patients and practitioners. Front Digit Health. 2023 Nov 17;5:1264780. doi: 10.3389/fdgth.2023.1264780.
37. Ezeamii VC, Okobi OE, Wambai-Sani H, et al. Revolutionizing Healthcare: How Telemedicine Is Improving Patient Outcomes and Expanding Access to Care. Cureus. 2024 Jul 5;16(7):e63881. doi: 10.7759/cureus.63881.
38. Shah AQ, Noronha N, Chin-See R, et al. The use and effects of telemedicine on complementary, alternative, and integrative medicine practices: a scoping review. BMC Complement Med Ther. 2023 Aug 2;23(1):275. doi: 10.1186/s12906-023-04100-x.
39. Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sens Int. 2021;2:100117. doi: 10.1016/j.sintl.2021.100117.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Daniela Pais, Tiago Amado, Pedro Monteiro, Paulo Ferreira
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
